Search Results 2331-2340 of 17344 for Cosmeceutical
The primary objective of the study is to measure efficacy of saruparib (AZD5305) plus camizestrant compared with physician's choice CDK4/6i plus ET in patients ...
Researchers found a link between "immune youth," a new term coined by Mayo researchers, and autoimmune disease. Latest stories.
ROCHESTER, Minn. — To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the[ ...
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early- ...
Minnesota Partnership for Biotechnology and Medical Genomics awards three collaborative research grants featured image · Mayo Clinic study suggests improved time ...
'Zombie' cells spark inflammation in severe fatty liver disease, Mayo Clinic researchers find · Joint study finds proton beam therapy helps patients with throat ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Dabrafenib is a potent and selective inhibitor of BRAF kinase activity. This is a Phase II, non-randomized, open-label study to assess the efficacy, safety, and ...
ROCHESTER, Minn. — Mayo Clinic researchers collaborated on a new study showing that the drug abemaciclib improves survival for people with high-risk, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!